Pacific Biosciences of California saw the highest growth of 2.49% in patent filings in June and 4.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.82% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Pacific Biosciences of California‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Pacific Biosciences of California has been focused on protecting inventions in United States(US) with 13 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 78% grants. The United States(US), China(CN), and European Patent Office(EPO) patent Office are among the top ten patent offices where Pacific Biosciences of California is filings its patents. Among the top granted patent authorities, Pacific Biosciences of California has 78% of its grants in United States(US) and 22% in European Patent Office(EPO).
Roche and Chinese University of Hong Kong could be the strongest competitors for Pacific Biosciences of California
In terms of grant share, Pacific Biosciences of California stands in fifth position among its competitors. Roche and Chinese University of Hong Kong secured the top positions according to recent patent publication data.
Patents related to genomics and nano tech lead Pacific Biosciences of California's portfolio
Pacific Biosciences of California has the highest number of patents in genomics followed by, nano tech and silicon photonics. For genomics, nearly 25% of patents were filed and no patents were granted in Q2 2024.
Dyes and pigments related patents lead Pacific Biosciences of California portfolio followed by image management, and active and passive safety
Pacific Biosciences of California has highest number of patents in dyes and pigments followed by image management, active and passive safety, manufacturing/industrial, and laboratory equipment. For dyes and pigments, nearly 100% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of Pacific Biosciences of California's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
